BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38863092)

  • 1. [Proposal and Analysis of "Ternary" Model of Sensitization for Proton Therapy].
    Wang X; Wang X; Du N; Wang L
    Zhongguo Yi Liao Qi Xie Za Zhi; 2024 May; 48(3):271-276. PubMed ID: 38863092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A ternary model of proton therapy based on boron medium radiosensitization and enhancement paths: a Monte Carlo simulation.
    Wang X; Shi L; Wang X; Wang L
    Transl Cancer Res; 2023 Oct; 12(10):2545-2555. PubMed ID: 37969397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical note: Monte Carlo study of the mechanism of proton-boron fusion therapy.
    Meyer HJ; Titt U; Mohan R
    Med Phys; 2022 Jan; 49(1):579-582. PubMed ID: 34822721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental investigation at CATANA facility of n-
    Mazzucconi D; Bortot D; Pola A; Fazzi A; Cazzola L; Conte V; Cirrone GAP; Petringa G; Cuttone G; Manti L; Agosteo S
    Phys Med; 2021 Sep; 89():226-231. PubMed ID: 34425513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental validation of proton boron capture therapy for glioma cells.
    Shtam T; Burdakov V; Garina A; Garaeva L; Tran NH; Volnitskiy A; Kuus E; Amerkanov D; Pack F; Andreev G; Lubinskiy A; Shabalin K; Verlov N; Ivanov E; Ezhov V; Lebedev D; Konevega AL
    Sci Rep; 2023 Jan; 13(1):1341. PubMed ID: 36693879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between proton boron fusion therapy (PBFT) and boron neutron capture therapy (BNCT): a monte carlo study.
    Jung JY; Yoon DK; Barraclough B; Lee HC; Suh TS; Lu B
    Oncotarget; 2017 Jun; 8(24):39774-39781. PubMed ID: 28427153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of effectiveness of equivalent dose during proton boron fusion therapy (PBFT) for brain cancer: A Monte Carlo study.
    Chiniforoush TA; Hadadi A; Kasesaz Y; Sardjono Y
    Appl Radiat Isot; 2021 Apr; 170():109596. PubMed ID: 33548811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First experimental proof of Proton Boron Capture Therapy (PBCT) to enhance protontherapy effectiveness.
    Cirrone GAP; Manti L; Margarone D; Petringa G; Giuffrida L; Minopoli A; Picciotto A; Russo G; Cammarata F; Pisciotta P; Perozziello FM; Romano F; Marchese V; Milluzzo G; Scuderi V; Cuttone G; Korn G
    Sci Rep; 2018 Jan; 8(1):1141. PubMed ID: 29348437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of boron compounds on the biological effectiveness of proton therapy.
    Manandhar M; Bright SJ; Flint DB; Martinus DKJ; Kolachina RV; Ben Kacem M; Titt U; Martin TJ; Lee CL; Morrison K; Shaitelman SF; Sawakuchi GO
    Med Phys; 2022 Sep; 49(9):6098-6109. PubMed ID: 35754208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BORON-ENHANCED BIOLOGICAL EFFECTIVENESS OF PROTON IRRADIATION: STRATEGY TO ASSESS THE UNDERPINNING MECHANISM.
    Kundrát P; Pachnerová Brabcová K; Jelínek Michaelidesová A; Zahradníček O; Danilová I; Štěpán V; Jamborová Z; Davídková M
    Radiat Prot Dosimetry; 2022 Aug; 198(9-11):527-531. PubMed ID: 36005957
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Hideghéty K; Brunner S; Cheesman A; Szabó ER; Polanek R; Margarone D; Tőkés T; Mogyorósi K
    Anticancer Res; 2019 May; 39(5):2265-2276. PubMed ID: 31092418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of moderator assembly dimension for accelerator boron neutron capture therapy of brain tumors using 7Li(p, n) neutrons at proton energy of 2.5 MeV.
    Tanaka K; Kobayashi T; Bengua G; Nakagawa Y; Endo S; Hoshi M
    Med Phys; 2006 Jun; 33(6):1688-94. PubMed ID: 16872076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of relative biological effectiveness for boron neutron capture therapy using the PHITS code coupled with a microdosimetric kinetic model.
    Horiguchi H; Sato T; Kumada H; Yamamoto T; Sakae T
    J Radiat Res; 2015 Mar; 56(2):382-90. PubMed ID: 25428243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Proton-Boron Reaction Increases the Radiobiological Effectiveness of Clinical Low- and High-Energy Proton Beams: Novel Experimental Evidence and Perspectives.
    Bláha P; Feoli C; Agosteo S; Calvaruso M; Cammarata FP; Catalano R; Ciocca M; Cirrone GAP; Conte V; Cuttone G; Facoetti A; Forte GI; Giuffrida L; Magro G; Margarone D; Minafra L; Petringa G; Pucci G; Ricciardi V; Rosa E; Russo G; Manti L
    Front Oncol; 2021; 11():682647. PubMed ID: 34262867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerator driven neutron source design via beryllium target and
    Khorshidi A
    J Cancer Res Ther; 2017; 13(3):456-465. PubMed ID: 28862209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPD-based evaluation of near threshold mono-energetic proton energies for the (7)Li(p,n)(7)Be production of neutrons for BNCT.
    Bengua G; Kobayashi T; Tanaka K; Nakagawa Y; Unesaki H
    Phys Med Biol; 2006 Aug; 51(16):4095-109. PubMed ID: 16885627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic out-of-field secondary neutron spectrometry and dosimetry in pencil beam scanning proton therapy.
    Trinkl S; Mares V; Englbrecht FS; Wilkens JJ; Wielunski M; Parodi K; Rühm W; Hillbrand M
    Med Phys; 2017 May; 44(5):1912-1920. PubMed ID: 28294362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear collision processes around the Bragg peak in proton therapy.
    Matsuzaki Y; Date H; Sutherland KL; Kiyanagi Y
    Radiol Phys Technol; 2010 Jan; 3(1):84-92. PubMed ID: 20821107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized beam shaping assembly for a 2.1-MeV proton-accelerator-based neutron source for boron neutron capture therapy.
    Torres-Sánchez P; Porras I; Ramos-Chernenko N; Arias de Saavedra F; Praena J
    Sci Rep; 2021 Apr; 11(1):7576. PubMed ID: 33828211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience.
    Porra L; Wendland L; Seppälä T; Koivunoro H; Revitzer H; Tervonen J; Kankaanranta L; Anttonen A; Tenhunen M; Joensuu H
    Cancer Biother Radiopharm; 2023 Apr; 38(3):184-191. PubMed ID: 36269660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.